PPP2R3A
Basic information
Region (hg38): 3:135965728-136147894
Previous symbols: [ "PPP2R3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPP2R3A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 15 | |||||
missense | 68 | 12 | 89 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 2 | 4 | |||
non coding | 0 | |||||
Total | 0 | 0 | 69 | 17 | 21 |
Variants in PPP2R3A
This is a list of pathogenic ClinVar variants found in the PPP2R3A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-136001518-T-C | not specified | Uncertain significance (Oct 16, 2023) | ||
3-136001636-G-T | PPP2R3A-related disorder | Likely benign (Sep 18, 2019) | ||
3-136001661-C-G | not specified | Uncertain significance (Mar 31, 2022) | ||
3-136001697-G-A | PPP2R3A-related disorder | Benign (Sep 25, 2019) | ||
3-136001698-A-G | PPP2R3A-related disorder | Benign (Oct 30, 2019) | ||
3-136001709-A-G | not specified | Likely benign (Jun 11, 2021) | ||
3-136001730-G-A | PPP2R3A-related disorder | Likely benign (Mar 31, 2022) | ||
3-136001821-A-G | PPP2R3A-related disorder | Likely benign (Apr 25, 2019) | ||
3-136001822-C-A | not specified | Uncertain significance (Aug 29, 2022) | ||
3-136001831-T-C | PPP2R3A-related disorder | Benign (Oct 30, 2019) | ||
3-136002009-G-T | PPP2R3A-related disorder | Benign (Oct 17, 2019) | ||
3-136002015-T-C | not specified | Uncertain significance (Oct 14, 2023) | ||
3-136002033-A-C | not specified | Uncertain significance (Mar 06, 2023) | ||
3-136002042-G-A | not specified | Uncertain significance (Jun 03, 2022) | ||
3-136002046-A-G | not specified | Uncertain significance (Dec 15, 2023) | ||
3-136002075-C-G | PPP2R3A-related disorder | Benign (Sep 18, 2019) | ||
3-136002081-A-G | not specified | Uncertain significance (Dec 02, 2022) | ||
3-136002082-C-T | not specified | Uncertain significance (Sep 07, 2022) | ||
3-136002120-G-A | not specified | Uncertain significance (Mar 01, 2024) | ||
3-136002189-A-G | not specified | Uncertain significance (Mar 27, 2023) | ||
3-136002194-C-T | PPP2R3A-related disorder | Benign (Feb 20, 2019) | ||
3-136002243-A-G | PPP2R3A-related disorder | Likely benign (Feb 28, 2019) | ||
3-136002318-T-A | not specified | Uncertain significance (Feb 28, 2024) | ||
3-136002327-G-C | not specified | Uncertain significance (Dec 19, 2022) | ||
3-136002348-A-G | not specified | Uncertain significance (Dec 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PPP2R3A | protein_coding | protein_coding | ENST00000264977 | 13 | 182219 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.623 | 0.377 | 125288 | 11 | 448 | 125747 | 0.00183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0389 | 591 | 588 | 1.00 | 0.0000287 | 7638 |
Missense in Polyphen | 294 | 305.34 | 0.96285 | 4070 | ||
Synonymous | -0.145 | 217 | 214 | 1.01 | 0.0000110 | 2106 |
Loss of Function | 5.00 | 10 | 47.0 | 0.213 | 0.00000239 | 632 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0250 | 0.0245 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000311 | 0.000308 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000230 | 0.000229 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: The B regulatory subunit might modulate substrate selectivity and catalytic activity, and also might direct the localization of the catalytic enzyme to a particular subcellular compartment.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Dopaminergic synapse - Homo sapiens (human);mRNA surveillance pathway - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Adrenergic signaling in cardiomyocytes - Homo sapiens (human);Sphingolipid signaling pathway - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;Wnt Signaling Pathway and Pluripotency;PI3K-Akt Signaling Pathway;Glycogen Metabolism;GPCR Dopamine D1like receptor;insulin Mam;EGFR1;insulin
(Consensus)
Recessive Scores
- pRec
- 0.132
Intolerance Scores
- loftool
- 0.870
- rvis_EVS
- 0.37
- rvis_percentile_EVS
- 74.78
Haploinsufficiency Scores
- pHI
- 0.153
- hipred
- Y
- hipred_score
- 0.718
- ghis
- 0.491
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.620
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ppp2r3a
- Phenotype
- skeleton phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- ppp2r3a
- Affected structure
- cardiac muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- protein dephosphorylation;regulation of phosphoprotein phosphatase activity;somite development
- Cellular component
- protein phosphatase type 2A complex
- Molecular function
- calcium ion binding;protein binding;protein phosphatase regulator activity